Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shen Fu Qiang Xin Pill
- Development stage
- Unknown
- Lead developer
- Tianjin Pharmaceutical Da Ren Tang Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Shen Fu Qiang Xin Pill is a proprietary traditional Chinese medicine (TCM) formulation developed and manufactured by Tianjin Pharmaceutical Da Ren Tang Group (formerly Tianjin Zhongxin Pharmaceutical Group). It is prepared from a mixture of several herbal ingredients, including Ginseng (*Renshen*), processed *Aconiti Lateralis Radix Praeparata* (*Fuzi*), *Rhei Radix et Rhizoma* (*Dahuang*), *Lepidii Semen* (*Tinglizi*), *Mori Cortex* (*Sangbaipi*), and *Polyporus* (*Zhuling*). Grounded in the traditional principles of tonifying Qi, warming Yang, strengthening the heart, and promoting diuresis, it is clinically used in China for the treatment of chronic heart failure (CHF), including heart failure with preserved ejection fraction (HFpEF), particularly in patients presenting with heart-kidney Yang deficiency syndrome.
- Brand names
- Da Ren Tang Shen Fu Qiang Xin WanShen Fu Qiang Xin PillShen-Fu Qiangxin PillsShenfu Qiangxin PillShenfu Qiangxin Wan
- Other names
- SFQXShen Fu Qiang XinShenfu Qiangxin
02
Targets
SIRT (Sirtuin family)FOXO3 (Forkhead box protein O3)mTOR (Mammalian target of rapamycin kinase)
Beyond the preview
Go deeper on Shen Fu Qiang Xin Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shen Fu Qiang Xin Pill.